Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Faculty of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Nutrients. 2020 May 2;12(5):1295. doi: 10.3390/nu12051295.
BACKGROUND: Malnutrition is associated with poor outcomes in patients with cancer, heart failure and chronic kidney disease. This study aimed to investigate the predictive value of the Controlling Nutritional Status (CONUT) score in coronary artery disease (CAD) patients. METHODS: We recruited a cohort of 3118 patients with CAD undergoing percutaneous coronary intervention (PCI) from 2005 to 2015. Nutritional status was evaluated using the CONUT score, with higher scores reflecting worse nutritional status. RESULTS: After adjustment for comorbidities and medication, an increased CONUT score was independently associated with a higher risk of acute myocardial infarction (AMI) (HR: 1.13; 95% CI: 1.03-1.24), cardiovascular (CV) death (HR: 1.18; 95% CI: 1.07-1.30), congestive heart failure (CHF) (HR: 1.11; 95% CI: 1.04-1.18), a major adverse cardiovascular event (MACE) (HR: 1.14; 95% CI: 1.07-1.22), and total CV events (HR: 1.11; 95% CI: 1.07-1.15). The subgroup analyses demonstrated that the association of the CONUT score existed independently of other established cardiovascular risk factors. In addition, CONUT significantly improved risk stratification for myocardial infarction (MI), cardiac death, CHF, MACEs and total CV events compared to conventional risk factors in CAD patients by the significant increase in the C-index (p < 0.05) and reclassification risk categories in cardiac death and MACEs. Conclusions The CONUT score improved the risk prediction of adverse events compared to traditional risk factors in CAD patients after percutaneous coronary intervention (PCI).
背景:营养不良与癌症、心力衰竭和慢性肾脏病患者的不良结局相关。本研究旨在探讨控制营养状况(CONUT)评分在冠状动脉疾病(CAD)患者中的预测价值。
方法:我们招募了 2005 年至 2015 年期间接受经皮冠状动脉介入治疗(PCI)的 3118 例 CAD 患者的队列。使用 CONUT 评分评估营养状况,得分越高反映营养状况越差。
结果:在调整合并症和药物治疗后,CONUT 评分升高与急性心肌梗死(AMI)(HR:1.13;95%CI:1.03-1.24)、心血管(CV)死亡(HR:1.18;95%CI:1.07-1.30)、充血性心力衰竭(CHF)(HR:1.11;95%CI:1.04-1.18)、主要不良心血管事件(MACE)(HR:1.14;95%CI:1.07-1.22)和总 CV 事件(HR:1.11;95%CI:1.07-1.15)风险升高独立相关。亚组分析表明,CONUT 评分与其他已确立的心血管危险因素独立相关。此外,与 CAD 患者中的传统危险因素相比,CONUT 显著增加了 C 指数(p < 0.05)和心脏死亡和 MACE 重新分类风险类别,从而显著改善了对心肌梗死(MI)、心脏死亡、CHF、MACE 和总 CV 事件的风险分层。结论:CONUT 评分在经皮冠状动脉介入治疗(PCI)后,与 CAD 患者中的传统危险因素相比,改善了不良事件的风险预测。
Front Endocrinol (Lausanne). 2024
Rev Assoc Med Bras (1992). 2018-9
Clin Chim Acta. 2018-10-22